Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Phase I-II trial of cyclophosphamide (C), mitroxantrone (M) and escalated doses of carboplatin (Car) supported by peripheral blood stem cells in women with metastatic breast cancer (MBC)

Phase I-II trial of cyclophosphamide (C), mitroxantrone (M) and escalated doses of carboplatin (Car) supported by peripheral blood stem cells in women with metastatic breast cancer (MBC). Proc Annu Meet Am Soc Clin Oncol. 1997; 16:A390.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.